Trails B is very important. I believe Shoulson and the FDA know this very well. What they are working out should be very interesting. Would love to be a fly on the wall. GLTA longs.
My thoughts as well, camp. And I do my investing based on science and scientists not message board posters and people like Adam Fartstain.
Right you are, jkokao.
As steve said in another thread:
"ilmn is fast becoming the most important company in the history of medicine. This stock will double or triple in value within 3 years. Buy now at the 160 level. You will be rewarded in the future. This stock is not going to $82."
Would not respond to the original message in the original thread because the header was posted by a bashing tool who wanted his header at the top of the message board. I won't oblige.
I'm happy to be one of the FEW retail holders of Illumina stock. Go Illumina!
Rudi honored in his hometown last week.
From the Warwick Beacon Online, 11/5/15:
"Imagine, in the future, being able to determine one’s risk of developing Alzheimer’s disease years in advance, through a simple blood test – and then being prescribed medication that works in the same way cholesterol-lowering drugs help stave off heart disease.
Dr. Rudolph Tanzi, a native Cranstonian, says recent developments have put that vision within reach."
Which recent developments, Dr. Tanzi? Let's see, which medication did he compare to those prescribed to fend off heart disease?
You are absolutely right, A Yahoo! User. The offer does not reflect (does not come close) the true value of the technology.